Policy

VA’s Oracle EHR Overhaul Could Cost $27 Billion

340B Reform: Who Profits From Drug Discounts Now?

Huddle #Trends

FDA Peptide Policy Raises Safety Concerns for Doctors

What Happens When Healthy People Leave the ACA Marketplace?

Medicare GLP-1 Bridge: Why Lower Prices Still Fall Short

PBM Reform 2026: What the New Rules Mean for Drug Prices and Your Patients

The Women's Health Paradox: Record VC, Federal Retreat

Huddle #Trends

CMS Brings AI Prior Authorization to Traditional Medicare: The WISeR Model Explained

Pharma’s New DTC Playbook: TikTok, TrumpRx, and What It Means for Physicians

ACA Enhanced Subsidies Expire Dec 31: What Physicians Need to Know

Huddle #Trends

How Medicaid Enrollment Changed: From COVID Expansion to Cuts

Pharma’s Direct-to-Consumer Strategy: Telehealth Deals Explained

Medicare Advantage Explained: Growth, Profits, and Problems

Huddle #Trends

Are Wearables for Everyone? RFK Jr., Health Data & the Risks

NYC Ambulance Rule Backfires: More Transfers, Less Continuity

Inefficiency Insights #83

Medicaid Cuts Ahead: How the Big Beautiful Bill Impacts Care

The Chaos Inside RFK Jr.’s HHS Takeover

Huddle #Trends

Women’s Health Funding Faces Political Threats Amid 2025 Shift

Huddle #Trends

Why Medicare Won’t Cover GLP-1 Drugs for Weight Loss

Why the VA’s $16B EHR Modernization Is Still Falling Short

The 340B Drug Program: How Hospitals Profit While Patients Pay

Huddle #Trends

CMS Reveals 15 Drugs for Medicare Negotiation, Including Ozempic

FDA Medical Device Pathways

Healthcare Concepts

For Better or For Worse: How Project 2025 Could Transform U.S. Healthcare

Hospital at Home: The Future of Care, Cost Savings & Tech

Huddle #Trends